GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
1HLC | P05162 | X-RAY CRYSTAL STRUCTURE OF THE HUMAN DIMERIC S-LAC LECTIN, L-14-II, IN COMPLEX WITH LACTOSE AT 2.9 ANGSTROMS RESOLUTION | |
1PPF | P08246 | X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN LEUKOCYTE ELASTASE (PMN ELASTASE) AND THE THIRD DOMAIN OF THE TURKEY OVOMUCOID INHIBITOR | HUMAN LEUKOCYTE ELASTASE (HLE) (NEUTROPHIL ELASTASE (HNE)) (E.C.3.4.21.37) COMPLEX WITH THE THIRD DOMAIN OF TURKEY OVOMUCOID INHIBITOR (OMTKY3) |
1PPF | P01004 | X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN LEUKOCYTE ELASTASE (PMN ELASTASE) AND THE THIRD DOMAIN OF THE TURKEY OVOMUCOID INHIBITOR | HUMAN LEUKOCYTE ELASTASE (HLE) (NEUTROPHIL ELASTASE (HNE)) (E.C.3.4.21.37) COMPLEX WITH THE THIRD DOMAIN OF TURKEY OVOMUCOID INHIBITOR (OMTKY3) |
2CKR | Q01786 | X-RAY CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THERMOBIFIDA FUSCA ENDOGLUCANASE CEL5A (E5) E355Q IN COMPLEX WITH CELLOTETRAOSE | ENDOGLUCANASE E-5 (E.C.3.2.1.4) |
1UU5 | Q8NJY3 | X-RAY CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMICOLA GRISEA CEL12A SOAKED WITH CELLOTETRAOSE | ENDO-BETA-1,4-GLUCANASE (E.C.3.2.1.4) |
1UU4 | Q8NJY3 | X-RAY CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMICOLA GRISEA CEL12A IN COMPLEX WITH CELLOBIOSE | ENDO-BETA-1,4-GLUCANASE (E.C.3.2.1.4) |
1W2U | Q8NJY3 | X-RAY CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMICOLA GRISEA CEL12A IN COMPLEX WITH A SOAKED THIO CELLOTETRAOSE | ENDOGLUCANASE (E.C.3.2.1.4) |
1UU6 | Q8NJY3 | X-RAY CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMICOLA GRISEA CEL12A IN COMPLEX WITH A SOAKED CELLOPENTAOSE | ENDO-BETA-1,4-GLUCANASE (E.C.3.2.1.4) |
1GZW | P09382 | X-RAY CRYSTAL STRUCTURE OF HUMAN GALECTIN-1 | |
1KCW | P00450 | X-RAY CRYSTAL STRUCTURE OF HUMAN CERULOPLASMIN AT 3.0 ANGSTROMS | CERULOPLASMIN, OXYGEN ATOM |
1D5M | P01903 | X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB | |
1D5M | P13760 | X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB | |
1D5M | P01552 | X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB | |
1D5M | 1D5M | X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB | |
2SEB | P01903 | X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II | |
2SEB | P13760 | X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II | |
2SEB | P01552 | X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II | |
2SEB | P02458 | X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II | |
1MYP | P05164 | X-RAY CRYSTAL STRUCTURE OF CANINE MYELOPEROXIDASE AT 3 ANGSTROMS RESOLUTION | MYELOPEROXIDASE (E.C.1.11.1.7) |
1W6P | P09382 | X-RAY CRYSTAL STRUCTURE OF C2S HUMAN GALECTIN-1 COMPLEXED WITH N- Acetyl-LACTOSAMINE | |
1W6O | P09382 | X-RAY CRYSTAL STRUCTURE OF C2S HUMAN GALECTIN-1 COMPLEXED WITH LACTOSE | |
1W6M | P09382 | X-RAY CRYSTAL STRUCTURE OF C2S HUMAN GALECTIN-1 COMPLEXED WITH GALACTOSE | |
1RIN | P02867 | X-RAY CRYSTAL STRUCTURE OF A PEA LECTIN-TRIMANNOSIDE COMPLEX AT 2.6 ANGSTROMS RESOLUTION | |
8XIA | P24300 | X-RAY ANALYSIS OF D-XYLOSE ISOMERASE AT 1.9 ANGSTROMS: NATIVE ENZYME IN COMPLEX WITH SUBSTRATE AND WITH A MECHANISM-DESIGNED INACTIVATOR | |
9XIA | P24300 | X-RAY ANALYSIS OF D-XYLOSE ISOMERASE AT 1.9 ANGSTROMS: NATIVE ENZYME IN COMPLEX WITH SUBSTRATE AND WITH A MECHANISM-DESIGNED INACTIVATOR | D-XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLEX WITH INACTIVATOR |
8G5A | A4JZ28 | X-31 hemagglutinin in complex with FL-1061 Fab | |
8G5A | 8G5A | X-31 hemagglutinin in complex with FL-1061 Fab | |
7ZJ8 | P03437 | X-31 Hemagglutinin Precursor HA0 at pH 7.5 after reneutralization | |
7ZJ8 | P10104 | X-31 Hemagglutinin Precursor HA0 at pH 7.5 after reneutralization | |
7ZJ6 | P03437 | X-31 Hemagglutinin Precursor HA0 at pH 7.5 | |
7ZJ6 | P10104 | X-31 Hemagglutinin Precursor HA0 at pH 7.5 | |
7ZJ7 | P03437 | X-31 Hemagglutinin Precursor HA0 at pH 4.8 | |
7ZJ7 | P10104 | X-31 Hemagglutinin Precursor HA0 at pH 4.8 | |
6GBI | Q86Y78 | Wnt signalling | Ly6/PLAUR domain-containing protein 6 |
6AHY | Q61091 | Wnt signaling complex | |
6AHY | P56703 | Wnt signaling complex | |
5FWV | Q96MU8 | Wnt modulator Kremen crystal form III at 3.2A | KREMEN PROTEIN 1 |
5FWU | Q96MU8 | Wnt modulator Kremen crystal form II at 2.8A | KREMEN PROTEIN 1 |
5FWT | Q96MU8 | Wnt modulator Kremen crystal form I at 2.10A | KREMEN PROTEIN 1 |
5FWS | Q96MU8 | Wnt modulator Kremen crystal form I at 1.90A | KREMEN PROTEIN 1 |
5KXC | 5KXC | Wisteria floribunda lectin in complex with GalNAc(beta1-4)GlcNAc (LacdiNAc) at pH 8.5. | |
5KXD | 5KXD | Wisteria floribunda lectin in complex with GalNAc(beta1-4)GlcNAc (LacdiNAc) at pH 6.5 | |
5KXE | 5KXE | Wisteria floribunda lectin in complex with GalNAc(beta1-4)GlcNAc (LacdiNAc) at pH 4.2 | |
5KXB | 5KXB | Wisteria floribunda lectin in complex with GalNAc | |
1M01 | O85361 | Wildtype Streptomyces plicatus beta-hexosaminidase in complex with product (GlcNAc) | Beta-N-acetylhexosaminidase (E.C.3.2.1.52) |
4H52 | Q194T1 | Wild-type influenza N2 neuraminidase covalent complex with 3-fluoro-Neu5Ac | |
6DZV | P31645 | Wild type human serotonin transporter in complex with 15B8 Fab bound to ibogaine in occluded conformation | 15B8 antibody heavy chain, 15B8 antibody light chain, Sodium-dependent serotonin transporter |
6DZV | 6DZV | Wild type human serotonin transporter in complex with 15B8 Fab bound to ibogaine in occluded conformation | 15B8 antibody heavy chain, 15B8 antibody light chain, Sodium-dependent serotonin transporter |
5TC9 | G0RVK1 | Wild type TrCel7A catalytic domain in a closed state | |
7VFQ | B7GN82 | Wild type GltA from Bifidobacterium infantis JCM 1222 complexed with lacto-N-tetraose |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024